FDA & EMEA to Consider Additional Test Results When Assessing New Drug Safety In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration
FDA Soon May Support Biomarker Tests The Food and Drug Administration is poised to throw its support behind a powerful new method of predicting the safety of experimen
Pharmaceutical Companies and FDA Making Strides Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Fo
Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional Hearings President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd
Tucson Nonprofit Seeks to Get Cures to Patients Faster A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and develo
C-Path Receives $675,000.00 Award for FDA Collaboration The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of wh
Valley Fever Cure a Step Closer The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent year
FDA Release: The Predictive Safety Testing Consortium The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Sa
C-Path to Spur Medical Innovation We all remember the Vioxx scare and authorities say it could happen again. However, the FDA is stepping up its efforts to improve
